Abstract

Cardiac diseases including heart failure (HF), are the leading cause of morbidity and mortality globally. Among the prominent characteristics of HF is the loss of β-adrenoceptor (AR)-mediated inotropic reserve. This is primarily due to the derangements in myocardial regulatory signaling proteins, G protein-coupled receptor (GPCR) kinases (GRKs) and β-arrestins (β-Arr) that modulate β-AR signal termination via receptor desensitization and downregulation. GRK2 and β-Arr2 activities are elevated in the heart after injury/stress and participate in HF through receptor inactivation. These GPCR regulators are modulated profoundly by nitric oxide (NO) produced by NO synthase (NOS) enzymes through S-nitrosylation due to receptor-coupled NO generation. S-nitrosylation, which is NO-mediated modification of protein cysteine residues to generate an S-nitrosothiol (SNO), mediates many effects of NO independently from its canonical guanylyl cyclase/cGMP/protein kinase G signaling. Herein, we review the knowledge on the NO system in the heart and S-nitrosylation-dependent modifications of myocardial GPCR signaling components GRKs and β-Arrs.

Highlights

  • Gprotein-coupled receptors (GPCRs) play important roles in the regulation of cardiac function

  • GPCR signaling have been shown to be profoundly affected by S-nitrosylation

  • GRK2 is is shown to be subjected to SNO regulation by both eNOS and iNOS, whereas β-Arr2 is shown to be subjected to SNO regulation by both eNOS and iNOS, whereas β-Arr2 is SS-nitrosylated by distinct NO synthase (NOS) isoforms resulting in various consequences

Read more

Summary

Introduction

Gprotein-coupled receptors (GPCRs) play important roles in the regulation of cardiac function. GPCRs are phosphorylated by GPCR kinases (GRKs) and thereafter associate with β-arrestins (β-Arr), which regulate receptor desensitization and internalization Activities of these regulatory molecules are augmented after stress/injury and result in excessive signal uncoupling and receptor desensitization which contribute to pathogenesis [1,2]. Important GPCR molecules in the heart including β-adrenoceptors (βARs), GRKs and β-Arr can be modulated by S-nitrosylation that is triggered by NOS-mediated generation of NO [11,12,13,14]. Three forms of NOS catalyzes the synthesis of NO, NOS1 (neuronal or nNOS), NOS2 (inducible or iNOS) and NOS3 (endothelial or eNOS) [9] They convert L-arginine and oxygen to L-citrulline and NO in the presence of nicotinamide-adenine-dinucleotide phosphate (NADPH) as co-substrate and tetrahydrobiopterin (BH4 ), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN) as cofactors [9,22]. Translocation of NOS to another compartment with a different oxygen levels alter its activity [18]

Endothelial Nitric Oxide Synthase
Neuronal Nitric Oxide Synthase
Nitric Oxide Signaling
NO-Mediated Signaling
Role of S-Nitrosylation in the HEART
Role of S-Nitrosylation in GPCR Signaling
Role of S-Nitrosylation in GRK Signaling
Role of S-Nitrosylation in β-Arrestin Signaling
Differential regulation β-arrestinsvia
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.